Agency Information Collection Request. 30-Day Public Comment Request, 29268-29269 [2021-11420]
Download as PDF
<![CDATA[
29268
Federal Register / Vol. 86, No. 103 / Tuesday, June 1, 2021 / Notices
because the revisions are nonsubstantive; for example, we revised the
CPGs’ formats to be consistent with
other CPGs, included references to other
aflatoxins CPGs, and included a
reference to the Memorandum of
Understanding between USDA/AMS
and FDA. Given the minor nature of
these revisions, an opportunity for
public comment before we finalize the
CPGs is unnecessary. However, as is the
case for all guidance documents, the
public may comment on any guidance
document at any time (§ 10.115(g)(5)).
The guidances represent the current
thinking of FDA on this topic. They do
not establish any rights for any person
and are not binding on FDA or the
public. You can use an alternative
approach if it satisfies the requirements
of the applicable statutes and
regulations.
These four CPGs update the
previously issued ‘‘CPG Sec. 555.400
Foods—Adulteration with Aflatoxin,’’
‘‘CPG Sec. 570.200 Brazil Nuts—
Adulteration with Aflatoxin,’’ ‘‘CPG
Sec. 570.375 Aflatoxin in Peanuts and
Peanut Products,’’ and ‘‘CPG Sec.
570.500 Pistachio Nuts—Aflatoxin
Adulteration.’’ The CPGs are intended
to provide guidance for FDA staff
regarding adulteration in human food,
Brazil nuts, peanuts and peanut
products, and pistachio nuts due to the
presence of aflatoxins and explain when
we may consider such foods to be
adulterated under section 402 of the
Federal Food, Drug, and Cosmetic Act
(21 U.S.C. 342).
II. Paperwork Reduction Act of 1995
These guidances contain no collection
of information. Therefore, clearance by
the Office of Management and Budget
under the Paperwork Reduction Act of
1995 is not required.
III. Electronic Access
Persons with access to the internet
may obtain the guidances at either
https://www.fda.gov/FoodGuidances or
https://www.regulations.gov. Use the
FDA website listed in the previous
sentence to find the most current
version of the guidances.
Dated: May 24, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for
Policy.
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Advancing the
response to COVID–19 Learning
Community Measure.
Type of Collection: New.
OMB No. 0990–NEW—Office within
OS—OMH
Abstract: The Department of Health
and Human Services, Office of Minority
Health (OMH) is seeking an approval by
OMB on a new information collection,
Advancing the response to COVID–19
Learning Community Measure (hereafter
COVID–19 Learning Community
Measure). The purpose of this data
collection is to gather quantitative and
qualitative data from Learning
Community members to monitor
learning community performance in
achieving process and outcome
measures over the course of the one-year
project. OMH will collect a set of
process and outcome measures from
program participants to assess the
degree to which the learning community
is effective in connecting subject matter
experts and public health leaders,
facilitating networking, and peer-to-peer
information sharing of promising
practices, programs, and/or policy.
The OMB clearance will enable OMH
to monitor and evaluate the COVID–19
Learning Community performance. The
data will be used to report the impact
of the COVID–19 Learning Community.
The ability to monitor and evaluate
performance in this manner, and to
work towards continuous program
improvement are basic functions that
OMH must be able to accomplish in
order to carry out goals for the COVID–
19 Learning Community and to ensure
the most effective and appropriate use
of resources.
Likely Respondents: Members and
staff from academia, community
organizations, local/state/federal
government, private sector, and tribal
government and services who serve
American Indian and Alaska Native
and/or racial and ethnic minorities.
[FR Doc. 2021–11388 Filed 5–28–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier OS–0990–new]
Agency Information Collection
Request. 30-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before July 1, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, Sherrette.Funn@hhs.gov
or (202) 795–7714. When submitting
comments or requesting information,
please include the document identifier
0990–New–30D and project title for
reference.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
SUMMARY:
jbell on DSKJLSW7X2PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN TABLE
Type of respondent
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
burden
hours
COVID–19 Learning Community Members .....................................................
200
1
5/60
17
........................
........................
........................
17
Total ..........................................................................................................
VerDate Sep<11>2014
18:20 May 28, 2021
Jkt 253001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
E:\FR\FM\01JNN1.SGM
01JNN1
Federal Register / Vol. 86, No. 103 / Tuesday, June 1, 2021 / Notices
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2021–11420 Filed 5–28–21; 8:45 am]
BILLING CODE 4150–29–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Integrative and Clinical Endocrinology and
Reproduction Study Section.
Date: June 23–24, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Biobehavioral Mechanisms of
Emotion, Stress and Health Study Section.
Date: June 23–25, 2021.
Time: 9:30 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maribeth Champoux,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7848, Bethesda, MD 20892, (301) 594–
3163, champoum@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel PAR–20–
211: Mid-Career Enhancement Awards to
Integrate Basic Behavioral, Biomedical, and/
or Social Scientific Processes (K18 No
Independent Clinical Trials).
VerDate Sep<11>2014
18:20 May 28, 2021
Jkt 253001
Date: June 23, 2021.
Time: 4:30 p.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maribeth Champoux,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
MSC 7848, Bethesda, MD 20892, 301–594–
3163, champoum@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Endocrinology, Metabolism,
Nutrition and Reproductive Sciences.
Date: June 24, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yunshang Piao, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive Room 6184,
Bethesda, MD 20892, 301–402–8402,
piaoy3@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Instrumentation, Environmental,
and Occupational Safety.
Date: June 28–29, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joonil Seog, SCD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–402–9791, joonil.seog@nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Pregnancy and Neonatology Study Section.
Date: June 28–30, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Andrew Maxwell Wolfe,
Ph.D., Scientific Review Officer, Center for
Scientific Review, NIH, 6701 Rockledge Dr.
Room 6214, Bethesda, MD 20892, 301–402–
3019, andrew.wolfe@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business Applications: Drug Discovery and
Development.
Date: June 28–29, 2021.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
29269
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Non-Viral Anti-Infective
Therapeutics.
Date: June 29, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bidyottam Mittra, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20894, 301–435–4057, bidyottam.mittra@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Musculoskeletal, Rehabilitation
and Skin Sciences.
Date: June 29–30, 2021.
Time: 9:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Chi-Wing Chow, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4110,
Bethesda, MD 20892, (301) 402–3912,
chowc2@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Mechanisms
of Disparities in Etiology and Outcomes of
Lung Cancer.
Date: June 29, 2021.
Time: 1:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ola Mae Zack Howard, BS,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192,
MSC 7806, Bethesda, MD 20892, 301–451–
4467, howardz@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Academic Industrial Partnerships for
Translation of Medical Technologies.
Date: July 1–2, 2021
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, (301) 237–
9870, xuguofen@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Endocrinology, Metabolism,
Nutrition and Reproductive Sciences.
E:\FR\FM\01JNN1.SGM
01JNN1
]]>Agencies
[Federal Register Volume 86, Number 103 (Tuesday, June 1, 2021)]
[Notices]
[Pages 29268-29269]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11420]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier OS-0990-new]
Agency Information Collection Request. 30-Day Public Comment
Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be received on or before July 1, 2021.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: Sherrette Funn, [email protected]
or (202) 795-7714. When submitting comments or requesting information,
please include the document identifier 0990-New-30D and project title
for reference.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: Advancing the response to COVID-19
Learning Community Measure.
Type of Collection: New.
OMB No. 0990-NEW--Office within OS--OMH
Abstract: The Department of Health and Human Services, Office of
Minority Health (OMH) is seeking an approval by OMB on a new
information collection, Advancing the response to COVID-19 Learning
Community Measure (hereafter COVID-19 Learning Community Measure). The
purpose of this data collection is to gather quantitative and
qualitative data from Learning Community members to monitor learning
community performance in achieving process and outcome measures over
the course of the one-year project. OMH will collect a set of process
and outcome measures from program participants to assess the degree to
which the learning community is effective in connecting subject matter
experts and public health leaders, facilitating networking, and peer-
to-peer information sharing of promising practices, programs, and/or
policy.
The OMB clearance will enable OMH to monitor and evaluate the
COVID-19 Learning Community performance. The data will be used to
report the impact of the COVID-19 Learning Community. The ability to
monitor and evaluate performance in this manner, and to work towards
continuous program improvement are basic functions that OMH must be
able to accomplish in order to carry out goals for the COVID-19
Learning Community and to ensure the most effective and appropriate use
of resources.
Likely Respondents: Members and staff from academia, community
organizations, local/state/federal government, private sector, and
tribal government and services who serve American Indian and Alaska
Native and/or racial and ethnic minorities.
Estimated Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
COVID-19 Learning Community Members......... 200 1 5/60 17
-------------------------------------------------------------------
Total................................... ............... ............... ............... 17
----------------------------------------------------------------------------------------------------------------
[[Page 29269]]
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance Officer, Office of the
Secretary.
[FR Doc. 2021-11420 Filed 5-28-21; 8:45 am]
BILLING CODE 4150-29-P
